Skip to main content
$101.36 $0.79 (0.8%)

04:00 PM EDT on 09/27/22

Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

CAPS Rating: 4 out of 5

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

Current Price $101.36 Mkt Cap $9.6B
Open $101.13 P/E Ratio 134.69
Prev. Close $101.36 Div. (Yield) $0.00 (0.0%)
Daily Range $100.27 - $102.75 Volume 797,807
52-Wk Range $71.88 - $109.26 Avg. Daily Vol. 757,912

Caps

How do you think NASDAQ:NBIX will perform against the market?

Add Stock to CAPS Watchlist

All Players

419 Outperform
45 Underperform
 

All-Star Players

86 Outperform
7 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NBIX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Rainman19 (< 20)
Submitted October 13, 2021

This cheap biotech stock doesn‘t get enough attention and that is a big chance!

zzlangerhans (99.75)
Submitted September 10, 2012

Neurocrine has been turning in solid pipeline progress for several years now but they haven't had much success holding gains in the share price. Now that the phase III trial of elagolix is in progress I expect at least a year before all 875 patients… More

Fools bullish on NASDAQ:NBIX are also bullish on:

Fools bearish on NASDAQ:NBIX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NBIX.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 9/1/2022 4:26:13 PM : Outperform Start Price: $105.55 NASDAQ:NBIX Score: +5.26

The company expects to expand the label for its lead therapy, Ingrezza, used to treat movement disorders. With that, should come expanded profits.

Recs

0
Member Avatar TMFSecurity (93.49) Submitted: 11/16/2021 9:14:14 AM : Underperform Start Price: $87.86 NASDAQ:NBIX Score: -37.59

10000000146

Recs

1
Member Avatar Rainman19 (< 20) Submitted: 10/13/2021 5:40:24 PM : Outperform Start Price: $101.94 NASDAQ:NBIX Score: +16.69

This cheap biotech stock doesn‘t get enough attention and that is a big chance!

Leaderboard

Find the members with the highest scoring picks in NBIX.

Score Leader

gsm1999

gsm1999 (53.78) Score: +4,088.98

The Score Leader is the player with the highest score across all their picks in NBIX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
gsm1999 53.78 3/8/2010 Outperform 5Y $2.30 +4,306.96% +217.98% +4,088.98 0 Comment
awsumrocker 90.49 3/10/2010 Outperform 3M $2.35 +4,213.19% +217.28% +3,995.91 0 Comment
stockamuteur 46.06 4/8/2010 Outperform 5Y $2.57 +3,843.97% +208.03% +3,635.94 0 Comment
Tadpole85 70.82 1/5/2010 Outperform 1Y $2.68 +3,682.09% +220.78% +3,461.31 0 Comment
borcobob 76.72 12/28/2009 Outperform 3Y $2.82 +3,494.33% +221.81% +3,272.52 0 Comment
royeknox 73.92 8/10/2009 Outperform 5Y $3.03 +3,245.21% +262.48% +2,982.73 0 Comment
MicroOptions 59.08 4/15/2010 Outperform 5Y $3.10 +3,169.68% +200.29% +2,969.39 0 Comment
MicroMikey 83.47 4/15/2010 Outperform 5Y $3.10 +3,169.68% +200.29% +2,969.39 0 Comment
minifesto 82.88 1/2/2009 Outperform 3Y $3.21 +3,057.63% +308.81% +2,748.83 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. foolshand < 20 7/27/2009 Outperform 3W $3.25 +3,018.77% +272.93% +2,745.84 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NBIX.